These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 16979835)

  • 1. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.
    Roeder F; Treiber M; Oertel S; Dinkel J; Timke C; Funk A; Garcia-Huttenlocher H; Bischof M; Weitz J; Harms W; Hensley FW; Buchler MW; Debus J; Krempien R
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1381-8. PubMed ID: 17275208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
    Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
    Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
    Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter.
    Zhang Q; Fu S; Liu T; Peng L; Huang G; Lu JJ
    Urol Oncol; 2009; 27(1):14-20. PubMed ID: 18367127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes after total mesorectal excision for rectal cancer.
    Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
    J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome.
    Prausová J; Lohynská R; Kubácková K; Linke Z; Malinová B; Kubala E; Novotný J
    Neoplasma; 2006; 53(3):263-8. PubMed ID: 16652199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral pelvic lymphadenectomy and total nerve sparing for locally advanced rectal cancer in Western patients.
    Di Matteo G; Peparini N; Maturo A; Di Matteo FM; Zeri KP; Redler A; Mascagni D
    Panminerva Med; 2001 Jun; 43(2):95-101. PubMed ID: 11449179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.